Date : 27 April 2026

| Company | Headquarters | Latest Update |
| Thermo Fisher Scientific Inc. | United States | In April 2026, Thermo Scientific equipment, consumables, and solutions support advancing research at every stage of the cell culture process. |
| Danaher Corporation | United States | In May 2025, Danaher Corporation, a worldwide science and technology innovator, announced the launch of a partnership with AstraZeneca to develop and commercialize new diagnostic tools and tests intended to support clinicians in better determining which patients would most benefit from precision medicine treatments. |
| Becton, Dickinson and Company (BD) | United States | In July 2026, BD Biosciences showcased a significant lineup of tools intended to expand the possibilities of cellular analysis. |
| Miltenyi Biotec | United States | Miltenyi Biotec provides research- and clinical-grade products for sample preparation, cell separation, flow cytometry, and cell culture applications. |
| Merck KGaA | Germany | In October 2026, Merck, a significant science and technology organization, entered into a collaboration with Promega Corporation, a worldwide life science services and solutions leader based in Madison, Wisconsin, in the US, to co-develop new technologies that advance drug screening and discovery. |
R&D:
Manufacturing Processes:
Patient Services:
The global cell isolation and analysis products market size was estimated at USD 18.7 billion in 2025 and is predicted to increase from USD 20.91 billion in 2026 to approximately USD 57.05 billion by 2035, expanding at a CAGR of 11.8% from 2026 to 2035. The cell isolation and analysis products market is growing because of increasing technical innovation, rising demand for targeted medicine, and government support for cell-driven therapies.

Speak with a healthcare analyst about your research, consulting, or platform needs.